Diet-Induced Microbiome's Impact on Heart Failure: A Double-Edged Sword

被引:5
作者
Rodrigues, Alexandre [1 ,2 ,3 ]
Goncalves, Alexandre [3 ,4 ]
Morais, Juliana [3 ,5 ]
Araujo, Ricardo [1 ,2 ]
Falcao-Pires, Ines [3 ,4 ]
机构
[1] Univ Porto, INEB Inst Biomed Engn, P-4200135 Porto, Portugal
[2] Univ Porto, i3S Inst Res & Innovat Hlth, P-4200135 Porto, Portugal
[3] Fac Med Univ Porto, Dept Surg & Physiol, P-4200319 Porto, Portugal
[4] Univ Porto, Dept Surg & Physiol, UnICRISE, Fac Med, P-4200319 Porto, Portugal
[5] Ctr Hlth Technol & Serv Res, CintesisRISE, P-4200450 Porto, Portugal
关键词
heart failure; HFrEF; HFpEF; microbiome; inflammation; diet; REDUCED EJECTION FRACTION; GUT MICROBIOTA; FATTY-ACIDS; INTESTINAL MICROBIOTA; MYOCARDIAL-INFARCTION; MEDITERRANEAN DIET; METABOLIC SYNDROME; RED MEAT; DISEASE; EPIDEMIOLOGY;
D O I
10.3390/nu15051223
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Heart failure (HF) is a debilitating disease with a significant clinical and economic impact worldwide. Multiple factors seem to increase the risk of developing HF, such as hypertension, obesity and diabetes. Since chronic inflammation plays a significant role in HF pathophysiology and gut dysbiosis is associated with low-grade chronic inflammation, the risk of cardiovascular diseases is likely modulated by the gut microbiome (GM). Considerable progress has been made in HF management. However, there is a need to find new strategies to reduce mortality and increase the quality of life, mainly of HFpEF patients, since its prevalence continues to rise. Recent studies validate that lifestyle changes, such as diet modulation, represent a potential therapeutic approach to improve several cardiometabolic diseases, although their effects on the GM and its indirect cardiac impact still warrant further research. Hence, in this paper, we aim to clarify the link between HF and the human microbiome.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Interleukin 27: a double-edged sword for offense and defense
    Yoshida, Hiroki
    Nakaya, Mako
    Miyazaki, Yoshiyuki
    JOURNAL OF LEUKOCYTE BIOLOGY, 2009, 86 (06) : 1295 - 1303
  • [42] Autophagy regulation in teleost fish: A double-edged sword
    Zhou, Zhixia
    He, Yanxin
    Wang, Shoushi
    Wang, Yin
    Shan, Peipei
    Li, Peifeng
    AQUACULTURE, 2022, 558
  • [43] Dupilumab for alopecia areata treatment: A double-edged sword?
    Jin, Peng
    Wei, Li
    Zhang, Qinqin
    Gao, Tingting
    Bai, Jianxue
    Dong, Liang
    Zhi, Lili
    JOURNAL OF COSMETIC DERMATOLOGY, 2022, 21 (11) : 5546 - 5548
  • [44] A double-edged sword? The cost of proctodeal trophallaxis in termites
    Mirabito, D.
    Rosengaus, R. B.
    INSECTES SOCIAUX, 2016, 63 (01) : 135 - 141
  • [45] Hepatic Stellate Cell: A Double-Edged Sword in the Liver
    Luo, Nianan
    Li, Jiangbin
    Wei, Yu
    Lu, Jianguo
    Dong, Rui
    PHYSIOLOGICAL RESEARCH, 2021, 70 (06) : 821 - 829
  • [46] Microgliosis: a double-edged sword in the control of food intake
    Salvi, Juliette
    Andreoletti, Pierre
    Audinat, Etienne
    Balland, Eglantine
    Ben Fradj, Selma
    Cherkaoui-Malki, Mustapha
    Heurtaux, Tony
    Lienard, Fabienne
    Nedelec, Emmanuelle
    Rovere, Carole
    Savary, Stephane
    Vejux, Anne
    Trompier, Doriane
    Benani, Alexandre
    FEBS JOURNAL, 2024, 291 (04) : 615 - 631
  • [47] Nrf2 in cancers: A double-edged sword
    Wu, Shijia
    Lu, Hong
    Bai, Yongheng
    CANCER MEDICINE, 2019, 8 (05): : 2252 - 2267
  • [48] Erlotinib Might Be a Double-Edged Sword in HCC Reply
    Dong, Jin-Zhong
    Wang, Li-Ping
    Zhang, Sai-Nan
    Zou, Zhuo-Lin
    Lu, Ming-Qin
    HEPATOLOGY, 2015, 61 (02) : 729 - 729
  • [49] Cholesterol Metabolism: A Double-Edged Sword in Hepatocellular Carcinoma
    Zhou, Fangli
    Sun, Xiaoli
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [50] Oral direct thrombin inhibition: a double-edged sword?
    Fragasso, Gabriele
    Corti, Angelo
    Loiacono, Ferdinando
    Margonato, Alberto
    D'Angelo, Armando
    HEART LUNG AND VESSELS, 2015, 7 (03) : 191 - 197